ecancermedicalscience

Conference Report

Aspirin, salicylates and cancer: conference report

24 May 2011
G Morgan, P Rothwell, J Burn, A Chan, L Mur, D Morton, J Cuzick, G McVie

On 23 November 2010, the Aspirin Foundation held a conference at the Royal Society of Medicine in London to consider the latest evidence for the role of aspirin in cancer prevention. The conference heard from leading specialists in the fields of epidemiology, genetics and gastroenterology, who discussed the implications of recent studies and considered how the role of aspirin might develop in the near future.

Related Articles

Eniola R Kadir, Kikelomo T Adesina, Olatunde Oyebanjo K Ibrahim, Beatrice O Owolabi, Olaniyi O Fatai, Tomilola M Olaseinde, Azeezat D Yakub, Hafsat A Ameen, Suleiman O Agodirin, Adegboyega A Fawole
Rajsinh Bhosale, Lamiya Pirzada, Safiyyah Khan, Aqsa Zainab, Shravya Subashini Sivaramakrishnan, Areeba Mariam Mehmood, Pawan Sapkota Upadhya
Roberta Monteiro Batista Sarmento, José Roberto Lapa e Silva, Gustavo Arantes Rosa Maciel, Claudia Ferrer, José Bines
Monali Swain, Sarbani Ghosh-Laskar, Lachlan McDowell, Christina Henson, Pierluigi Bonomo, Sadhana Kannan, Timothy Malouff, Akihiro Homma, Alexander Rühle, Anna Lee, Francesca Caparrotti, James Bates, Jorgen Johansen, Juliette Thariat, Marco Ferrari, Miguel Mayo-Yáñez, Sarah Hamilton, Sue S Yom, Hisham Mehanna, Petr Szturz
Catalina Vargas Añazco, Álvaro Torres Soto, Renata Soto Díaz, Martín Urra, Maite Azócar, Mauricio Camus Appuhn, Francisco Dominguez Covarrubias, César Sánchez Rojel, Francisco Acevedo Claros